Dr. Christopher L. Robinson is a Strategic Advisor at Doc2Doc.
Dr. Robinson attended Georgetown University, where he completed a bachelor’s degree in biochemistry. He completed his MD-PhD at the Tri-Institutional MD-PhD Program at Weill Cornell Medical College, Rockefeller University, and Memorial Sloan Kettering Cancer Center where he discovered in collaboration with Dr. Charles Rice, the 2020 Nobel Prize in Medicine, and Dr. Shuibing Chen a novel anti-Zika virus therapeutic during the Zika virus epidemic. He is now completing his training as an anesthesia resident physician-scientist at Harvard Medical School- BIDMC with research focused primarily on developing new chronic pain therapeutics.
His passion for teamwork and education comes from his leadership running a startup during his PhD and understanding that knowledge is power. He knows healthcare providers are focusing on treating patients, and with the right focused financial knowledge and support from Doc2Doc, they can continue to do so and support themselves and their loved ones for the decades to come.